Cited by 61Alzheimer's disease research and treatmentsAutophagy in Disease and TherapyMitochondrial Function and Pathology

A novel lysosome‐to‐mitochondria signaling pathway disrupted by amyloid‐β oligomers

Open access
Norambuena, Andrés, Wallrabe, Horst, Cao, Rui, Wang, Dora Bigler, Silva, Antonia, Svindrych, Zdenek, Periasamy, Ammasi, Hu, Song +3 more·2018·The EMBO Journal

Abstract

The mechanisms of mitochondrial dysfunction in Alzheimer's disease are incompletely understood. Using two-photon fluorescence lifetime microscopy of the coenzymes, NADH and NADPH, and tracking brain oxygen metabolism with multi-parametric photoacoustic microscopy, we show that activation of lysosomal mechanistic target of rapamycin complex 1 (mTORC1) by insulin or amino acids stimulates mitochondrial activity and regulates mitochondrial DNA synthesis in neurons. Amyloid-β oligomers, which are precursors of amyloid plaques in Alzheimer's disease brain and stimulate mTORC1 protein kinase activity at the plasma membrane but not at lysosomes, block this Nutrient-induced Mitochondrial Activity (NiMA) by a mechanism dependent on tau, which forms neurofibrillary tangles in Alzheimer's disease brain. NiMA was also disrupted in fibroblasts derived from two patients with tuberous sclerosis complex, a genetic disorder that causes dysregulation of lysosomal mTORC1. Thus, lysosomal mTORC1 couples nutrient availability to mitochondrial activity and links mitochondrial dysfunction to Alzheimer's disease by a mechanism dependent on the soluble building blocks of the poorly soluble plaques and tangles.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.15252/embj.2018100241

Cites

62 of 62 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Certain Aβ oligomers may, depending on the presence of tau, block mitochondrial activity through lysosomal mTORC1 protein kinase activity but potentially stimulate mitochondrial activity in the absence of tau.

    “Recent work has shown that certain Aβ oligomers may, depending on the presence of tau, block mitochondrial activity through lysosomal mTORC1 protein kinase activity but potentially stimulate mitochondrial activity in the absence of tau (42).”

    From Molecular subtyping of Alzheimer’s disease using RNA sequencing data reveals novel mechanisms and targets (2021) · cites this paper as [42]

    The Results and Discussion (page unavailable) report that Aβ oligomers block nutrient-induced mitochondrial activity through a tau-dependent mechanism. But they attribute the inhibition to mTORC1 activation at the plasma membrane, not at lysosomes. In tau-knockout neurons, mitochondrial activity was insensitive to Aβ oligomers; the paper does not report that the oligomers stimulate it. (LLM, conf=0.90)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Norambuena, A., Wallrabe, H., Cao, R., Wang, D. B., Silva, A., Svindrych, Z., Periasamy, A., Hu, S., Tanzi, R. E., Kim, D. Y., & Bloom, G. S.
Affiliations
  • University of Virginia (US)
  • Harvard University (US)
Corresponding author
  • Norambuena, Andrés
  • Bloom, George S
Venue
The EMBO Journal
Published
2018-10-22
Volume
37
Issue
22
ISSN
  • 0261-4189 (ISSN-L)
  • 1460-2075
OpenAlex
W2895929116
Cited by
61
References
62
Citations by year
2026: 4 · 2025: 7 · 2024: 5 · 2023: 3 · 2022: 10 · 2021: 8 · 2020: 10 · 2019: 10 · 2018: 4
FWCI
5.50
Type
journal article
Language
en
Open access
Locations
  • The EMBO Journal (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • HHS|National Institutes of Health (RF1 AG051085, RF1 AG048080, R01 AG014713, S10 OD016446, R21 AG052062, P01 AG015379)
  • BrightFocus Foundation
  • Owens Family Foundation
  • Alzheimer's Association (ZEN‐16‐363266)
  • Cure Alzheimer's Fund
  • Webb and Tate Wilson
  • Virginia Chapter of the Lady's Auxilliary of the Fraternal Order of Eagles
  • University of Virginia President's Fund for Excellence
  • Alzheimer's and Related Diseases Research Award Fund (17‐5)
  • Virginia Chapter of the Lady's Auxiliary of the Fraternal Order of Eagles
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Epidemiology › Autophagy in Disease and Therapy
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
Keywords
mTORC1, amyloid-beta oligomers, Alzheimer's disease, mitochondrial dysfunction, mitochondrial DNA synthesis, NADH, NADPH, cerebral oxygen consumption, tau protein, neurofibrillary tangles, tuberous sclerosis complex, insulin, amino acids
MeSH terms
Mechanistic Target of Rapamycin Complex 1, Alzheimer Disease, Animals, Brain, Cell Membrane, Fibroblasts, Humans, Lysosomes, Mitochondria, Tuberous Sclerosis, Signal Transduction, Amyloid beta-Peptides, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review